Breast Cancer
Conditions
Interventions
and 
PEM-DOT 
imaging 
after 
in 
30 
cancer 
one 
Sponsors
The First Affiliated Hospital of the Air Force Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 80 years; 2. Gender: female; 3. Diagnosed by clinicopathology; 4. 30 breast cancer patients who plan to receive neoadjuvant chemotherapy; 5. 10 patients with benign space-occupying breast lesions but with other high-risk factors for tumors or unexplained increase in tumor markers; 6. After discussion by MDT, PET/CT examination is deemed necessary; 7. The length of the lesion is >= 0.5 cm; 8. In the prone position, the drooping length of the breast of the lesion exceeds 5 cm; 9. The size of both breasts is less than or equal to E cup, which can be included in the equipment; 10. Signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Minors, pregnant women, and lactating women; 2. Severe liver and kidney dysfunction (alanine aminotransferase is 8-10 times the upper limit of normal, and serum creatinine is 186-442umol/L); 3. A history of drug allergy or a drug has been stopped due to adverse reactions when using a drug; 4. Patients who have had serious adverse reactions when using imaging agents.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Standard uptake value (SUV);Oxygen saturation of blood; | — |
Countries
China
Contacts
Public ContactKang Fei
The First Affiliated Hospital of the Air Force Medical University
Outcome results
None listed